Clinical Response to Osimertinib Compared to Other Tyrosine Kinase Inhibitors and Chemotherapy in Non-Small Cell Lung Cancer. acmcr. 2020;4(6):1108-1115. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22422